At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
CGMS and insulin pumpdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study of the Safety, Feasibility, and Potential Efficacy of Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG)
Johns Hopkins Bloomberg School of Public Health·interventional·Posted Dec 11, 2009·Updated Feb 9, 2022
In Brief
A clinical study evaluating CGMS and insulin pump for Diabetic Gastroparesis. Completed, enrolled 45 participants across 7 sites.
Detailed Summary
A pilot study to assess the safety, feasibility, and potential (uncontrolled) efficacy of continuous glucose monitoring (CGMS) in conjunction with an insulin pump to improve glycemic control for treatment of type 1 and type 2 diabetic patients with gastroparesis
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Gastroparesis
CountriesUnited States
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 2009
Enrollment StartMay 2011
Primary CompletionNov 2014
Study CompletionJan 2015
TodayJul 2026
First PostedDec 11, 2009
Enrollment StartMay 1, 2011
Primary CompletionNov 1, 2014
Study CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 16.6 years ago
Interventions
CGMS and insulin pumpdevice
Use of continuous glucose monitoring system and insulin pump